In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Despite Surgeon Support, NEJM Vertebroplasty Articles Spark Slowdown, Reimbursement Review

Executive Summary

Two controversial clinical studies published in the New England Journal of Medicine are forcing Medtronic and Orthovita to convince primary care physicians of the benefits of kyphoplasty and vertebroplasty.
Advertisement

Related Content

Medtronic Looks to Strengthen Spine with Osteotech Purchase
Welsh Carson Sits in K2M Driver's Seat
Welsh Carson Sits in K2M Driver's Seat
Physicians and Industry Respond to Recent Vertebroplasty Studies
Top Device Stories of 2009: A Year of Economic Revival and Regulatory Risk
Has Orthovita's Fight Finally Ended?
Top Device Stories of 2009: A Year of Economic Revival and Regulatory Risk
SpineAlign Medical Inc.
Critical Vertebroplasty Studies Raise Questions
Critical Vertebroplasty Studies Raise Questions

Related Companies

Advertisement
UsernamePublicRestriction

Register

IV003232

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel